Abstract:MicroRNAs (miRNAs) are endogenous, non-coding, small RNAs, which negatively regulate gene expression in a sequence-specific manner via translational repression and/or mRNA degradation. Their discovery revealed a new and exciting aspect of post-transcriptional gene regulation that is universally involved in cellular homeostasis. Importantly, the advent of miRNAs added another level of complication in the already complex regulatory networks of the cell, undermining that RNA molecules in general, should be considered gene regulators of equal importance with proteins. Recently, the scientific community drew attention to the miRNA field for an additional reason: an increasing line of evidence indicated that miRNA genes are tightly connected with the process of tumorigenesis. Indeed, several miRNAs have already been demonstrated to behave as oncogenes or tumor suppressor genes in many types of cancer. Even though the underlying mechanisms by which miRNAs can destabilize the normal cellular processes, promoting cell transformation and tumor progression, are not well understood, genetic and epigenetic alterations most probably play a critical role. Significant technologic advances facilitated the profiling of the miRNA expression patterns in normal and cancer tissues and discovered an unexpected greater reliability of miRNA expression signatures in classifying cancer types than the respective signatures of protein-coding genes. Along with this extraordinary diagnostic potential, miRNAs have also proved their prognostic value in predicting clinical behaviors of cancer patients. The aim of this review is to describe miRNA expression and how its deregulation is involved in the pathophysiology of human cancers.

The Mirna-Kallikrein Interaction: a Mosaic of Epigenetic Regulation in Cancer

The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer.

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Kallikreins are involved in an miRNA network that contributes to prostate cancer progression.

Kallikrein-related Peptidase 5 Induces Mirna-Mediated Anti-Oncogenic Pathways in Breast Cancer.

MicroRNAs in Colorectal Cancer As Markers and Targets: Recent Advances.

Synthesis and Regulation of miRNA, Its Role in Oncogenesis, and Its Association with Colorectal Cancer Progression, Diagnosis, and Prognosis

Mirna Genetic Alterations in Human Cancers

Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer

How MicroRNAs Command the Battle against Cancer

MicroRNAs and the hallmarks of cancer

Micrornas, an Active and Versatile Group in Cancers

MicroRNA Epigenetic Alterations in Human Cancer: One Step Forward in Diagnosis and Treatment

Regulation of microRNAs by epigenetics and their interplay involved in cancer

MicroRNAs: Novel Regulators in the Hallmarks of Human Cancer.

A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes

Regulation of Epithelial-Mesenchymal Transition Through Micrornas: Clinical and Biological Significance of Micrornas in Breast Cancer

MicroRNAs as important players in regulating cancer through PTEN/PI3K/AKT signalling pathways

Epigenetic Alterations of Tumor Marker Micrornas: Towards New Cancer Therapies.

MicroRNAs in Epithelial–Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy

Post‐transcriptional Regulation of the Tumor Suppressor Mir‐139‐5p and a Network of Mir‐139‐5p‐mediated Mrna Interactions in Colorectal Cancer